Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma

  1. Moreau, P.
  2. Van De Donk, N.W.C.J.
  3. Nahi, H.
  4. Oriol, A.
  5. Nooka, A.K.
  6. Martin, T.
  7. Rosinol, L.
  8. Karlin, L.
  9. Benboubker, L.
  10. Mateos, M.-V.
  11. Popat, R.
  12. Martínez-López, J.
  13. Sidana, S.
  14. Delforge, M.
  15. Pei, L.
  16. Trancucci, D.
  17. Olyslager, Y.
  18. Uhlar, C.
  19. Stephenson, T.
  20. Rampelbergh, R.V.
  21. Banerjee, A.
  22. Kobos, R.
  23. Usmani, S.Z.
Journal:
Future Oncology

ISSN: 1744-8301 1479-6694

Year of publication: 2023

Volume: 19

Issue: 12

Pages: 811-818

Type: Review

DOI: 10.2217/FON-2023-0171 GOOGLE SCHOLAR lock_openOpen access editor